The Newsroom

Investigations  /  10.11.2019

Investigation of Inogen Inc.

Inogen, Inc. (INGN) Accused of Misstating its Strong Sales and Financial Success

According to the class action complaint against the company for alleged violations of the Securities Exchange Act of 1934, on November 7, 2017, Inogen touted its strong sales and financial success, predicting “strong results in 2018…” and increased its guidance range for full year 2017 revenue.  Inogen subsequently increased its FY18 guidance range, emphasizing that the company’s strong direct-to-customer sales were the result of the strong sales acumen of its salesforce. These quarterly statements were often followed by significant increases in stock price that resulted in a class period high of more than $282 per share on September 14, 2018.  In February 2019, a series of news articles were released criticizing the company’s narrative and denouncing its sales tactics, negatively affecting the company’s stock.  Then, on February 26, 2019, Inogen announced poor 4Q18 and FY18 financial results, which caused Inogen’s stock to fall nearly $34 per share, or more than 24% to close at $106.28 per share on February 27, 2019.  The stock now trades at around $46 per share, representing another 57% decline in value.

Inogen, Inc. (INGN) Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can send us a message via the Shareholder Information form below.

Shareholder Information

  • Please Note: Neither the submission to nor the receipt of information by Robbins LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

Please Note: Neither the submission to nor the receipt of information by Robbins Arroyo LLP or one of its attorneys through this website constitutes an agreement by our firm to represent the individual and does not create an attorney-client relationship. Please do not send confidential or sensitive information through this website. This information should be communicated through a direct contact with an individual at the firm.

How can we help you?

CONTACT US TODAY | 1 800 350 6003 or [email protected]

Tell us your concerns